In one of the first clinical applications of magnetic nanoparticles to reach the market, Endomagnetics has developed a technology that offers a safer, cheaper way to detect whether breast tumours have spread
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.